DNA methylation and breast carcinogenesis

被引:355
作者
Widschwendter, M [1 ]
Jones, PA [1 ]
机构
[1] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA
关键词
breast cancer; DNA methylation; carcinogenesis; prevention; early detection;
D O I
10.1038/sj.onc.1205606
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Knowledge about breast carcinogenesis has accumulated during the last decades but has barely been translated into strategies for early detection or prevention of this common disease. Changes in DNA methylation have been recognized as one of the most common molecular alterations in human neoplasia and hypermethylation of gene-promoter regions is being revealed as one of the most frequent mechanisms of loss of gene function. The heritability of methylation states and the secondary nature of the decision to attract or exclude methylation support the idea that DNA methylation is adapted for a specific cellular memory. According to Hanahan and Weinberg, there are six novel capabilities a cell has to acquire to become a cancer cell: limitless replicative potential, self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, evasion of programmed cell death, sustained angiogenesis and tissue invasion and metastasis. This review highlights how DNA-methylation contributes to these features and offers suggestions about how these changes could be prevented, reverted or used as a 'tag' for early detection of breast cancer or, preferably, for detection of premalignant changes.
引用
收藏
页码:5462 / 5482
页数:21
相关论文
共 244 条
  • [21] Reducing mammary cancer risk through premature stem cell senescence
    Boulanger, CA
    Smith, GH
    [J]. ONCOGENE, 2001, 20 (18) : 2264 - 2272
  • [22] DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine
    Bovenzi, V
    Lê, NLO
    Cóté, S
    Sinnett, D
    Momparler, LF
    Momparler, RL
    [J]. ANTI-CANCER DRUGS, 1999, 10 (05) : 471 - 476
  • [23] Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation
    Brenner, AJ
    Stampfer, MR
    Aldaz, CM
    [J]. ONCOGENE, 1998, 17 (02) : 199 - 205
  • [24] SRC-RELATED PROTEIN-TYROSINE KINASES ARE PHYSICALLY ASSOCIATED WITH THE SURFACE-ANTIGEN CD36 IN HUMAN DERMAL MICROVASCULAR ENDOTHELIAL-CELLS
    BULL, HA
    BRICKELL, PM
    DOWD, PM
    [J]. FEBS LETTERS, 1994, 351 (01) : 41 - 44
  • [25] Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas
    Burger, AM
    Zhang, X
    Li, H
    Ostrowski, JL
    Beatty, B
    Venanzoni, M
    Papas, T
    Seth, A
    [J]. ONCOGENE, 1998, 16 (19) : 2459 - 2467
  • [26] Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
    Burke, WM
    Jin, XH
    Lin, HJ
    Huang, M
    Liu, R
    Reynolds, RK
    Lin, JY
    [J]. ONCOGENE, 2001, 20 (55) : 7925 - 7934
  • [27] 14-3-3σ is required to prevent mitotic catastrophe after DNA damage
    Chan, TA
    Hermeking, H
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1999, 401 (6753) : 616 - 620
  • [28] Chen B, 2000, CANCER RES, V60, P3290
  • [29] Down-regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer
    Chen, LM
    Hodge, GB
    Guarda, LA
    Welch, JL
    Greenberg, NM
    Chai, KX
    [J]. PROSTATE, 2001, 48 (02) : 93 - 103
  • [30] Prostasin serine protease inhibits breast cancer Invasiveness and is transcriptionally regulated by promoter DNA methylation
    Chen, LM
    Chai, KX
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (03) : 323 - 329